loading
Schlusskurs vom Vortag:
$4.14
Offen:
$4.15
24-Stunden-Volumen:
1.65M
Relative Volume:
1.39
Marktkapitalisierung:
$264.11M
Einnahmen:
$488.00K
Nettoeinkommen (Verlust:
$-41.44M
KGV:
-4.2688
EPS:
-0.93
Netto-Cashflow:
$-31.47M
1W Leistung:
-7.24%
1M Leistung:
+28.06%
6M Leistung:
+16.42%
1J Leistung:
+67.86%
1-Tages-Spanne:
Value
$3.84
$4.1866
1-Wochen-Bereich:
Value
$3.73
$4.52
52-Wochen-Spanne:
Value
$2.01
$5.6395

Cardiff Oncology Inc Stock (CRDF) Company Profile

Name
Firmenname
Cardiff Oncology Inc
Name
Telefon
858-952-7570
Name
Adresse
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Name
Mitarbeiter
33
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
CRDF's Discussions on Twitter

Vergleichen Sie CRDF mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CRDF
Cardiff Oncology Inc
3.97 275.42M 488.00K -41.44M -31.47M -0.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-08 Eingeleitet Ladenburg Thalmann Buy
2025-06-24 Eingeleitet Jefferies Hold
2024-09-06 Eingeleitet Craig Hallum Buy
2022-01-05 Eingeleitet William Blair Outperform
2021-12-08 Eingeleitet Robert W. Baird Outperform
2021-08-09 Fortgesetzt Maxim Group Buy
2020-10-22 Eingeleitet H.C. Wainwright Buy
2020-10-08 Eingeleitet Piper Sandler Overweight
Alle ansehen

Cardiff Oncology Inc Aktie (CRDF) Neueste Nachrichten

pulisher
10:36 AM

How strong is Cardiff Oncology Inc. company’s balance sheetUnlock superior stock analysis tools - jammulinksnews.com

10:36 AM
pulisher
10:03 AM

Why is Cardiff Oncology Inc. stock attracting strong analyst attentionAchieve consistent profits with proven methods - jammulinksnews.com

10:03 AM
pulisher
09:53 AM

New Product Launches: Will They Boost Cardiff Oncology Inc. Stock in 2025Free Consultation - Newser

09:53 AM
pulisher
08:36 AM

How Interest Rate Changes Impact Cardiff Oncology Inc. Stock PerformanceFree Join Group - Newser

08:36 AM
pulisher
08:35 AM

How Cardiff Oncology Inc. stock performs during market volatilityFree Stock Index Interpretation - Newser

08:35 AM
pulisher
06:36 AM

Is Cardiff Oncology Inc. Stock Overbought or Oversold RSI Indicator AnalysisHigh Confidence Trade Setups - Newser

06:36 AM
pulisher
06:19 AM

Is Cardiff Oncology Inc. stock a growth or value playFree Real-Time Trading Opportunities - Newser

06:19 AM
pulisher
05:45 AM

Cardiff Oncology Inc. Company’s Quarterly Earnings Growth: What the Numbers SayProfit Focused Trade Alerts - Newser

05:45 AM
pulisher
05:44 AM

When is Cardiff Oncology Inc. stock expected to show significant growthFree Consultation - jammulinksnews.com

05:44 AM
pulisher
Jul 25, 2025

Is Cardiff Oncology Inc. a good long term investmentHigh-octane investment gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Published on: 2025-07-25 15:19:32 - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Cardiff Oncology Inc. stockExplosive capital appreciation - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Cardiff Oncology Inc. Stock Analysis and ForecastExplosive trading opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Cardiff Oncology Inc. stock priceFast-track wealth growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Cardiff Oncology Inc. stock price move sharplyFree Day Trading Recommendations - Newser

Jul 22, 2025
pulisher
Jul 18, 2025

Cardiff Oncology: Volatility Afoot With Onvansertib Update Near-Term (NASDAQ:CRDF) - Seeking Alpha

Jul 18, 2025
pulisher
Jul 15, 2025

Why Cardiff Oncology Inc. stock attracts strong analyst attentionAlpha Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Cardiff Oncology (CRDF) Initiated with a Buy at Ladenburg Thalmann & Co. - The Globe and Mail

Jul 11, 2025
pulisher
Jul 11, 2025

Cardiff Oncology (NASDAQ:CRDF) Earns Buy Rating from Analysts at LADENBURG THALM/SH SH - Defense World

Jul 11, 2025
pulisher
Jul 11, 2025

Brokerages Set Cardiff Oncology, Inc. (NASDAQ:CRDF) Price Target at $11.70 - Defense World

Jul 11, 2025
pulisher
Jul 09, 2025

Cardiff Oncology, Inc. (CRDF) Reports 40% Response Rate in mTNBC Trial of Onvansertib + Paclitaxel - MSN

Jul 09, 2025
pulisher
Jul 08, 2025

Cardiff Oncology stock initiated with Buy rating at Ladenburg Thalmann By Investing.com - Investing.com Canada

Jul 08, 2025
pulisher
Jul 08, 2025

Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies - GlobeNewswire

Jul 08, 2025
pulisher
Jul 08, 2025

International Business Times - FinancialContent

Jul 08, 2025
pulisher
Jul 03, 2025

Cardiff Oncology Up 16%, Insider Buyers Are Up 35% - simplywall.st

Jul 03, 2025
pulisher
Jul 03, 2025

While institutions invested in Cardiff Oncology, Inc. (NASDAQ:CRDF) benefited from last week's 16% gain, retail investors stood to gain the most - Yahoo Finance

Jul 03, 2025
pulisher
Jun 27, 2025

Cardiff Oncology: Delayed Trial Data Update Unnerves Investors But Gives Bulls A Final Buy Low Opportunity - Seeking Alpha

Jun 27, 2025

Finanzdaten der Cardiff Oncology Inc-Aktie (CRDF)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Cardiff Oncology Inc-Aktie (CRDF) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Levine James E.
Chief Financial Officer
Dec 18 '24
Buy
5.00
2,400
12,000
67,716
Levine James E.
Chief Financial Officer
Dec 16 '24
Buy
3.83
2,564
9,820
62,564
TANNENBAUM RENEE P
Director
Dec 12 '24
Buy
3.42
10,000
34,224
20,000
PACE GARY W
Director
Dec 11 '24
Buy
2.60
350,115
910,299
1,047,876
PACE GARY W
Director
Dec 11 '24
Buy
2.60
11,500
29,900
1,059,376
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):